Leaflet PYLERA 140mg / 125mg / 125mg capsules

Product code:: W72178001
Indicated for:: Helicobacter pylori eradication with omeprazole and prevention of recurrence of associated peptic ulcer disease
Route of administration:: oral
Substance:: bismuth subcitrate + metronidazole + tetracycline (bismuth compound+nitroimidazole antibacterial+tetracycline antibacterial)
ATC: A02BD08 — Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Combinations for eradication of helicobacter pylori

Precautions:

Take this medicine with food.

This medicine may affect your ability to drive or use machines.

Read the package leaflet before use.

Seek medical advice if severe or persistent diarrhea occurs.

Do not use this medicine while breastfeeding.

Do not use this medicine during pregnancy.

Do not give to children for whom it is contraindicated.

Avoid alcohol during treatment.

Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.

Avoid excessive exposure to sunlight or UV radiation.

This medicine may affect the liver.

This medicine may have important interactions with other medicines.

This medicine may affect the nerves or nervous system.

Do not split, crush, or chew this medicine.

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

This medicine may increase the risk of heart rhythm disturbances.

This medicine may increase the risk of seizures.

This medicine may cause vision disturbances.

Substance:: bismuth subcitrate + metronidazole + tetracycline
Product code:: W72178001
Concentration:: 140mg / 125mg / 125mg
Pharmaceutical form:: capsules
Product type:: Generic medicine
Prescription status:: P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.